These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 23747780)

  • 1. The impact of mild therapeutic hypothermia on platelet reactivity in comatose survivors of cardiac arrest with acute myocardial infarction treated with ticagrelor.
    Umińska JM; Ratajczak J; Pstrągowski K; Buszko K; Nadolny K; Fabiszak T; Steblovnik K; Noč M; Kubica J
    Cardiol J; 2024; 31(3):472-478. PubMed ID: 35514087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet Therapy, Pretreatment, and Primary PCI: Every Minute Counts.
    Silvain J; Montalescot G; Guedeney P
    J Am Coll Cardiol; 2024 Jun; 83(25):2640-2642. PubMed ID: 38897673
    [No Abstract]   [Full Text] [Related]  

  • 3. Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial.
    Steg PG; Harrington RA; Emanuelsson H; Katus HA; Mahaffey KW; Meier B; Storey RF; Wojdyla DM; Lewis BS; Maurer G; Wallentin L; James SK;
    Circulation; 2013 Sep; 128(10):1055-65. PubMed ID: 23900047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial.
    Zarif B; Soliman L; Sabry NA; Said E
    Thromb J; 2022 Aug; 20(1):44. PubMed ID: 35978315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified ticagrelor loading doses according to the vasodilator-stimulated phosphoprotein phosphorylation index improve the clinical outcome in ST-elevation myocardial infarction patients with high on-treatment platelet reactivity.
    Liu Y; Kang S; Li X; Liu Z; Gao Y; Wang X
    Cardiol J; 2023; 30(5):771-780. PubMed ID: 34581430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI.
    Yang A; Pon Q; Lavoie A; Crawford JJ; Harenberg S; Zimmermann RH; Booker J; Kelly S; Lavi S; Cantor WJ; Mehta SR; Bagai A; Goodman SG; Cheema AN; Dehghani P
    J Thromb Thrombolysis; 2018 Feb; 45(2):225-233. PubMed ID: 29170875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.
    Burt T; Noveck RJ; MacLeod DB; Layton AT; Rowland M; Lappin G
    Clin Transl Sci; 2017 Sep; 10(5):337-350. PubMed ID: 28419765
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic therapy for patients with STEMI undergoing primary PCI.
    Franchi F; Rollini F; Angiolillo DJ
    Nat Rev Cardiol; 2017 Jun; 14(6):361-379. PubMed ID: 28230176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.
    Siller-Matula JM; Specht S; Kubica J; Alexopoulos D; De Caterina R; Hobl EL; Jilma B; Christ G; Lang IM
    Br J Clin Pharmacol; 2016 Nov; 82(5):1343-1350. PubMed ID: 27366874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Rationale of the APELOT Trial: A Randomized, Open-Label, Multicenter, Phase IV Study to Evaluate the Antiplatelet Effect of Different Loading Dose of Ticagrelor in Patients With Non-ST Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Liu HL; Wei YJ; Jin ZG; Zhang J; Ding P; Yang SL; Luo JP; Ma DX; Liu Y; Han W
    Medicine (Baltimore); 2016 May; 95(22):e3756. PubMed ID: 27258504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic Study.
    Alexopoulos D; Barampoutis N; Gkizas V; Vogiatzi C; Tsigkas G; Koutsogiannis N; Davlouros P; Hahalis G; Nylander S; Parodi G; Xanthopoulou I
    Clin Pharmacokinet; 2016 Mar; 55(3):359-67. PubMed ID: 26315810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update.
    Teng R
    Clin Pharmacokinet; 2015 Nov; 54(11):1125-38. PubMed ID: 26063049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor versus high dose clopidogrel in ST-segment elevation myocardial infarction patients with high platelet reactivity post fibrinolysis.
    Alexopoulos D; Perperis A; Koniari I; Karvounis H; Patsilinakos S; Ziakas A; Barampoutis N; Panagiotidis T; Akinosoglou K; Hahalis G; Xanthopoulou I
    J Thromb Thrombolysis; 2015 Oct; 40(3):261-7. PubMed ID: 25680893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiplatelet therapy in acute coronary syndrome. Prehospital phase: nothing, aspirin or what?].
    Bauer T; Hamm C
    Herz; 2014 Nov; 39(7):803-7. PubMed ID: 25315248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet: life on the razor's edge between hemorrhage and thrombosis.
    Coller BS
    Transfusion; 2014 Sep; 54(9):2137-46. PubMed ID: 25092268
    [No Abstract]   [Full Text] [Related]  

  • 16. Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI.
    Alexopoulos D; Gkizas V; Patsilinakos S; Xanthopoulou I; Angelidis C; Anthopoulos P; Makris G; Perperis A; Karanikas S; Koutsogiannis N; Davlouros P; Deftereos S; Chiladakis J; Hahalis G
    J Am Coll Cardiol; 2013 Sep; 62(10):940-1. PubMed ID: 23747780
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.
    Alexopoulos D; Xanthopoulou I; Gkizas V; Kassimis G; Theodoropoulos KC; Makris G; Koutsogiannis N; Damelou A; Tsigkas G; Davlouros P; Hahalis G
    Circ Cardiovasc Interv; 2012 Dec; 5(6):797-804. PubMed ID: 23169985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study.
    Parodi G; Bellandi B; Valenti R; Migliorini A; Marcucci R; Carrabba N; Giurlani L; Gensini GF; Abbate R; Antoniucci D
    Am Heart J; 2014 Jun; 167(6):909-14. PubMed ID: 24890542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
    Velders MA; Abtan J; Angiolillo DJ; Ardissino D; Harrington RA; Hellkamp A; Himmelmann A; Husted S; Katus HA; Meier B; Schulte PJ; Storey RF; Wallentin L; Gabriel Steg P; James SK;
    Heart; 2016 Apr; 102(8):617-25. PubMed ID: 26848185
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.